Related references
Note: Only part of the references are listed.The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease
Soie Kwon et al.
DIABETES CARE (2020)
Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins
Yeo Min Yoon et al.
JOURNAL OF PINEAL RESEARCH (2020)
Mesenchymal stromal cell ? based therapies for acute kidney injury: progress in the last decade
Barbara Fazekas et al.
KIDNEY INTERNATIONAL (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Benefits of Metformin in Attenuating the Hallmarks of Aging
Ameya S. Kulkarni et al.
CELL METABOLISM (2020)
Cardiac Remodeling in Chronic Kidney Disease
Nadine Kaesler et al.
TOXINS (2020)
NF-κB as the mediator of metformin's effect on ageing and ageing-related diseases
Gonul Kanigur Sultuybek et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrPC-dependent enhancement of the mitochondrial function
Yong-Seok Han et al.
JOURNAL OF PINEAL RESEARCH (2019)
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program
Daniela Gnani et al.
AGING CELL (2019)
Prelamin A mediates myocardial Inflammation in dilated and HIV-associated cardiomyopathies
Daniel Brayson et al.
JCI INSIGHT (2019)
Senescence and aging: Causes, consequences, and therapeutic avenues
Domhnall McHugh et al.
JOURNAL OF CELL BIOLOGY (2018)
Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology
Norberto Perico et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder
Ellen Neven et al.
KIDNEY INTERNATIONAL (2018)
The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function
Lucie Henaut et al.
TOXINS (2018)
Hyperphosphatemia Promotes Senescence of Myoblasts by Impairing Autophagy Through Ilk Overexpression, A Possible Mechanism Involved in Sarcopenia
Patricia Sosa et al.
AGING AND DISEASE (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Senescence in Health and Disease
Shenghui He et al.
CELL (2017)
Challenges and opportunities for stem cell therapy in patients with chronic kidney disease
LaTonya J. Hickson et al.
KIDNEY INTERNATIONAL (2016)
The global burden of chronic kidney disease: estimates, variability and pitfalls
Richard J. Glassock et al.
Nature Reviews Nephrology (2016)
Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells
Anne-Laure Egesipe et al.
NPJ AGING AND MECHANISMS OF DISEASE (2016)
Hyperphosphatemia induces cellular senescence in human aorta smooth muscle cells through integrin linked kinase (ILK) up-regulation
Nuria Troyano et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction
Rita C. Cavaglieri et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Metformin: From Mechanisms of Action to Therapies
Marc Foretz et al.
CELL METABOLISM (2014)
Mesenchymal Stem Cells from Rats with Chronic Kidney Disease Exhibit Premature Senescence and Loss of Regenerative Potential
Barbara Mara Klinkhammer et al.
PLOS ONE (2014)
Uremic Toxin p-Cresol Induces Akt-Pathway-Selective Insulin Resistance in Bone Marrow-Derived Mesenchymal Stem Cells
Hyunjin Noh et al.
STEM CELLS (2014)
Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-B activation
Olga Moiseeva et al.
AGING CELL (2013)
Prelamin A Accelerates Vascular Calcification Via Activation of the DNA Damage Response and Senescence-Associated Secretory Phenotype in Vascular Smooth Muscle Cells
Yiwen Liu et al.
CIRCULATION RESEARCH (2013)
Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease
Joseph Satriano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress
Gulinuer Muteliefu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Uremia induces functional incompetence of bone marrow-derived stromal cells
Hyunjin Noh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Sirtuin 1 Retards Hyperphosphatemia-Induced Calcification of Vascular Smooth Muscle Cells
Aya Takemura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Yuchen Chien et al.
GENES & DEVELOPMENT (2011)
Examination of the expanding pathways for the regulation of p21 expression and activity
Yong-Sam Jung et al.
CELLULAR SIGNALLING (2010)
Prelamin A Acts to Accelerate Smooth Muscle Cell Senescence and Is a Novel Biomarker of Human Vascular Aging
Cassandra D. Ragnauth et al.
CIRCULATION (2010)
Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function Clinical recommendations
Anders Frid et al.
DIABETES CARE (2010)
Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
Ana I. Morales et al.
KIDNEY INTERNATIONAL (2010)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Nuclear lamins, diseases and aging
Anna Mattout et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
M Gnecchi et al.
NATURE MEDICINE (2005)
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
M Eriksson et al.
NATURE (2003)
Comparison of multi-lineage cells from human adipose tissue and bone marrow
DA De Ugarte et al.
CELLS TISSUES ORGANS (2003)
Share Paper
